Found: 14
Select item for more details and to access through your institution.
An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 4, p. 391, doi. 10.1111/j.1365-2036.2005.02287.x
- By:
- Publication type:
- Article
Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor- α medications among patients with inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 653, doi. 10.1111/apt.13936
- By:
- Publication type:
- Article
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 11, p. 1142, doi. 10.1111/apt.13616
- By:
- Publication type:
- Article
Long-term outcome of a third anti- TNF monoclonal antibody after the failure of two prior anti- TNFs in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 5, p. 459, doi. 10.1111/j.1365-2036.2012.05214.x
- By:
- Publication type:
- Article
Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 3, p. 239, doi. 10.1111/j.1365-2036.2012.05173.x
- By:
- Publication type:
- Article
Anti-TNF associated psoriasis: authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 2, p. 309, doi. 10.1111/j.1365-2036.2011.04945.x
- By:
- Publication type:
- Article
Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 11/12, p. 1318, doi. 10.1111/j.1365-2036.2011.04866.x
- By:
- Publication type:
- Article
Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 11/12, p. 1328, doi. 10.1111/j.1365-2036.2011.04871.x
- By:
- Publication type:
- Article
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 3, p. 253, doi. 10.1111/j.1365-2036.2009.04037.x
- By:
- Publication type:
- Article
Infliximab vs. Adalimumab for Crohn's disease: authors' reply.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 11/12, p. 1509, doi. 10.1111/j.1365-2036.2007.03548.x
- By:
- Publication type:
- Article
Systematic Review of Complementary and Alternative Medicine Treatments in Inflammatory Bowel Diseases.
- Published in:
- Journal of Crohn's & Colitis, 2015, v. 9, n. 1, p. 86, doi. 10.1093/ecco-jcc/jju007
- By:
- Publication type:
- Article
The inflammatory bowel diseases and ambient air pollution: a novel association.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 11, n. 4, p. 163
- By:
- Publication type:
- Article
Iatrogenic Trichuris suis infection in a patient with Crohn disease.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article